Atrial Flutter
📧 Sign up to get email alerts when something new happens for Atrial Flutter.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Efficacy and Safety of Catheter Ablation of Atrial Fibrillation in Patients With Thyroid Hormone Stabilization
This clinical trial is evaluating the efficacy and safety of catheter ablation for atrial fibrillation in patients stabilized on thyroid hor…
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: DeteCtiON and Stroke PreventIon by MoDEl ScRreenING for Atrial Fibrillation [NA]
The study evaluating detection and model-based screening to prevent stroke in atrial fibrillation has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Suture Closure AFtEr VEIN Access for Cardiac Procedures (SAFE-VEIN) Trial [NA]
The SAFE-VEIN trial evaluating suture closure after venous access for cardiac procedures has completed, with results posted in May 2024.
-
FDA approval · 2024-05-15FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's supplemental application for sotalol hydrochloride (generic). This action authorizes changes to the previously approved …
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Ablation Index in Standard vs. High Power Radiofrequency Ablation for Typical Atrial Flutter: A Randomized Study (AITAF) [NA]
A randomized study comparing Ablation Index in standard-power versus high-power radiofrequency ablation for typical atrial flutter is not ye…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Propagation ANalysis for Arrhythmogenic Conduction Elimination to Prevent Atrial Flutter and Fibrillation (PANACEA-AF)
A completed clinical trial (PANACEA-AF, NCT03737838) from the University of Chicago evaluating propagation analysis to prevent atrial flutte…
-
FDA approval · 2024-04-30FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for sotalol hydrochloride from Aurobindo Pharma Limited, authorizing the generic product's approval.
-
FDA approval · 2024-04-30FDA Approved: DOFETILIDE 0.125MG — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for dofetilide 0.125 mg (granules) by Granules Pharmaceuticals Inc., expanding the product's availab…
-
FDA approval · 2024-04-29FDA Approved: LANOXIN — Supplemental Application (Advanz Pharma (US) Corp.)
The FDA approved a supplemental application for LANOXIN (digoxin) submitted by Advanz Pharma (US) Corp.
-
FDA approval · 2024-04-23FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (FRESENIUS KABI USA, LLC)
FDA approved the original application for Verapamil hydrochloride as a generic drug, manufactured by Fresenius Kabi USA, LLC. Verapamil hydr…
-
FDA approval · 2024-04-01FDA Approved: IBUTILIDE FUMARATE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an original ANDA for ibutilide fumarate (generic) from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
-
FDA approval · 2024-01-12FDA Approved: SOTYLIZE — Supplemental Application (Azurity Pharmaceuticals, Inc.)
The FDA approved a supplemental application for SOTYLIZE (sotalol hydrochloride) from Azurity Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion [Phase 4]
Phase 4 trial comparing bolus dosing of methohexital and propofol for direct current cardioversion in patients with atrial fibrillation or a…
-
FDA approval · 2023-10-23FDA Approved: MULTAQ — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for MULTAQ (dronedarone) from Sanofi-Aventis U.S. LLC.
-
FDA approval · 2023-09-12FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application for sotalol hydrochloride from Oxford Pharmaceuticals, LLC under an ANDA.
-
FDA approval · 2023-09-11FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approves Apotex Corp.'s supplemental application for sotalol hydrochloride, enabling a generic version of the antiarrhythmic for clinica…
-
CLINICAL_TRIALS trial_result · 2023-07-12Clinical Trial Update: A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at Least 70 Years of Age Reduces the Risk of Stroke [Phase 4]
Phase 4 trial assessing whether identifying undiagnosed atrial fibrillation in people aged 70+ reduces stroke risk.
-
FDA approval · 2023-06-15FDA Approved: BETAPACE — Supplemental Application (Legacy Pharma USA, Inc.)
The FDA approved a supplemental application for BETAPACE (sotalol hydrochloride) from Legacy Pharma USA, Inc.
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Wire Instrumentation Using Radiofrequency Energy to Impact Transseptal Efficiency [NA]
A completed clinical trial evaluating wire instrumentation using radiofrequency energy to impact transseptal efficiency for atrial fibrillat…
-
FDA approval · 2023-03-07FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved Slate Run Pharmaceuticals, LLC's generic diltiazem hydrochloride through an original ANDA.
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: Oral vs Intravenous Diltiazem for Rapid Atrial Fibrillation/Flutter Trial [Phase 4]
Phase 4 trial comparing oral versus intravenous diltiazem for rapid atrial fibrillation/flutter has completed with results posted in 2023.
-
FDA approval · 2023-03-01FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved Upsher-Smith's generic diltiazem hydrochloride (Original Application) as a generic version of diltiazem hydrochloride.
-
FDA approval · 2023-02-28FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application for Sotalol hydrochloride from Oxford Pharmaceuticals, LLC.
-
FDA approval · 2023-02-21FDA Approved: PROPAFENONE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved a generic Propafenone hydrochloride product from Aurobindo Pharma Limited under an Original Application. This marks market entr…
-
FDA approval · 2022-12-13FDA Approved: ESMOLOL HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' Esmolol hydrochloride in sodium chloride as a generic injectable under an Original Application (ANDA).